Effect of uncontrolled hyperglycemia on levels of adhesion molecules in patients with diabetes mellitus type 2

ObjectiveUncontrolled diabetes has become a major cause of mortality and morbidity by reason of vascular angiopathy. The aim of this study was to evaluate the concentrations of soluble forms of vascular adhesion molecule-1 (sVCAM-1), intercellular adhesion molecule-1 (sICAM-1), E-selectin, and thrombomodulin in patients with well-controlled and uncontrolled diabetes type 2.MethodsThe study was conducted on 62 patients with diabetes. Group I consisted of 35 patients with well-controlled diabetes. The second group included 27 patients with uncontrolled diabetes with micro-albuminuria. A control group was made up of 25 healthy volunteers. The concentrations of sVCAM-1, sICAM-1, sE-selectin, and soluble thrombomodulin were assayed in plasma. Serum concentration of creatinine was measured and the plasma concentrations of fasting glucose and glycated hemoglobin (HbA1c) determined.ResultsLower concentrations of ICAM-1 were found in the group of uncontrolled diabetes patients compared with those with well-controlled disease. In patients with uncontrolled diabetes, VCAM-1 levels were significantly higher compared with the group with well-controlled diabetes. In patients with uncontrolled diabetes a positive correlation was obtained between glomerular filtration rate and sE-selectin and a negative correlation between the levels of creatinine and ICAM-1, although there was a positive correlation between (HbA1c) and ICAM-1.ConclusionThe study confirmed the participation of the inflammatory process associated with impaired vascular endothelial function in the pathogenesis of type 2 diabetes. The opposite effect of uncontrolled hyperglycemia on adhesion molecules suggests different functions of VCAM-1 and ICAM-1 in complications of diabetes.概要目的评估可溶性血管细胞间黏附分子 (sVCAM-1)、可溶性细胞间黏附分子 (sICAM-1)、可溶性选择素E 和可溶性血栓调节蛋白在血糖控制良好和不受控制的2 型糖尿病患者中的水平。创新点对2 型糖尿病患者的血管内皮炎症标记物进行评估。方法62 例糖尿病患者分成两组: 第一组包括35 个血糖控制良好的糖尿病患者, 第二组包括27 个未控制血糖并伴有微蛋白尿的糖尿病患者。对照组由25 名健康志愿者组成。测定血浆中sVCAM-1、sICAM-1、可溶性选择素E 和可溶性血栓调节蛋白的浓度, 同时测定血清肌酐及血浆中空腹血糖和糖化血红蛋白 (HbA1c) 的浓度。结论与血糖控制良好的糖尿病组相比, 未控制血糖组具有相对低的ICAM-1 水平和更高的VCAM-1 水平。未控制血糖组中患者的糖化血红蛋白和ICAM-1 之间呈正相关, 肾小球滤过率和可溶性选择素E 之间呈正相关, 而肌酐和ICAM-1 之间呈负相关。研究证实2 型糖尿病的发病机理中炎症过程的出现与血管内皮功能受损有关。未受控制的高血糖对粘附分子的反向作用表明, 在糖尿病的并发症中VCAM-1和ICAM-1具有不同功能。

[1]  L. Gesualdo,et al.  [Diabetic nephropathy and cardiovascular risk]. , 2017, Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia.

[2]  J. Górriz,et al.  Pathophysiological role and therapeutic implications of inflammation in diabetic nephropathy. , 2012, World journal of diabetes.

[3]  L. Gnudi,et al.  Endothelial Factors and Diabetic Nephropathy , 2011, Diabetes Care.

[4]  K. Adeli,et al.  Increased plasma methylglyoxal level, inflammation, and vascular endothelial dysfunction in diabetic nephropathy. , 2011, Clinical biochemistry.

[5]  M. T. Grande,et al.  Role of inflammation in túbulo-interstitial damage associated to obstructive nephropathy , 2010, Journal of Inflammation.

[6]  L. A. Lachica,et al.  Nefropatía diabética y riesgo cardiovascular , 2010 .

[7]  J. Małyszko,et al.  Cardiovascular complications in patients with diabetic nephropathy , 2008 .

[8]  G. Bertino,et al.  Plasma ICAM-1 and VCAM-1 levels in type 2 diabetic patients with and without microalbuminuria. , 2008, Minerva medica.

[9]  J. Suwaidi,et al.  Cardiovascular Surgery, Hamad General Hospital – Hamad Medical , 2022 .

[10]  M. Urban,et al.  Analysis of selected new biomarkers of early atherosclerosis process in children and adolescents with diabetes type 1 , 2007 .

[11]  S. Szmit,et al.  Review article Diabetic microangiopathy – a current look at the pathogenesis and the clinical implications for cardiovascular diseases , 2007 .

[12]  LloydChambless,et al.  Elevated Markers of Endothelial Dysfunction Predict Type 2 Diabetes Mellitus in Middle-Aged Men and Women From the General Population , 2006 .

[13]  G. Lip,et al.  Endothelial dysfunction: methods of assessment and application to hypertension. , 2004, Current pharmaceutical design.

[14]  K. Empen,et al.  Differential effects of fenofibrate versus atorvastatin on the concentrations of E-selectin and vascular cellular adhesion molecule-1 in patients with type 2 diabetes mellitus and mixed hyperlipoproteinemia: a randomized cross-over trial , 2003, Cardiovascular diabetology.

[15]  T. Stalker,et al.  A novel role for calpains in the endothelial dysfunction of hyperglycemia , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[16]  B. Çakır,et al.  Plasma Soluble Intercellular Adhesion Molecule 1 Levels Are Increased in Type 2 Diabetic Patients with Nephropathy , 2002, Hormone Research in Paediatrics.

[17]  A. M. Lefer,et al.  Mechanisms of amelioration of glucose-induced endothelial dysfunction following inhibition of protein kinase C in vivo. , 2002, Diabetes.

[18]  H. Parving,et al.  Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death. , 2002, Diabetes.

[19]  B. Isermann,et al.  Effect of alpha-lipoic acid on the progression of endothelial cell damage and albuminuria in patients with diabetes mellitus: an exploratory study. , 2001, Diabetes research and clinical practice.

[20]  N. Lassen,et al.  Diabetic microangiopathy, a factor enhancing the functional significance of peripheral occlusive arteriosclerotic disease. , 1984, Clinical physiology.

[21]  D. Kereiakes,et al.  Endothelial dysfunction. , 2003, Circulation.